Home › NDC Lookup › RxCUI directory › RxCUI 2693095

2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya] — RxCUI 2693095

Name: 2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya] (RxCUI 2693095)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2693095 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2693095

Official name2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asTremfya 200 MG per 2 ML Auto-Injector; Tremfya 200 MG in 2 ML Auto-Injector

FDA products mapped3

Package NDCs mapped10

Reported Medicaid activity (SDUD)32,717 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Guselkumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Tremfya is approved to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis in adults and in children as young as 6 years old (who weigh at least about 88 lbs)....
What conditions does Tremfya actually treat?
Not necessarily. For plaque psoriasis and psoriatic arthritis, Tremfya is given as a subcutaneous injection — meaning under the skin — and adults can self-inject at home using the...
How do I take this medication — do I have to go to a clinic every time?

📖 Read our full Guselkumab Injection guide →

🕸️ Concept Web — How 2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya] RxCUI 2693095 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Guselkumab 1928588 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tremfya 1928593 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Guselkumab Auto-Injector 2118738 SCDF
- Guselkumab Injectable Product 1928590 SCDG
- Guselkumab Auto-Injector [Tremfya] 2118740 SBDF
- Tremfya Injectable Product 1928596 SBDG
- Auto-Injector 1649570 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 2 ML guselkumab 100 MG/ML Auto-Injector 2693094 SCD
- Guselkumab 100 MG/ML 1928589 SCDC
- Guselkumab 100 MG/ML [Tremfya] 1928594 SBDC
Packs 2

Fixed collections of drugs packaged and sold together, like dose packs.
- {2 (2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]) } Pack [Tremfya Induction Pack for Crohn's Disease] 2711638 BPCK
- {2 (2 ML guselkumab 100 MG/ML Auto-Injector) } Pack 2711637 GPCK

Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

2 ML guselkumab 100 MG/ML Auto-Injector SCD · 2693094
{2 (2 ML guselkumab 100 MG/ML Auto-Injector) } Pack GPCK · 2711637
Guselkumab 100 MG/ML SCDC · 1928589
Guselkumab Auto-Injector SCDF · 2118738
Guselkumab Injectable Product SCDG · 1928590

Brand-Name Concepts

{2 (2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]) } Pack [Tremfya Induction Pack for Crohn's Disease] BPCK · 2711638
Guselkumab 100 MG/ML [Tremfya] SBDC · 1928594
Guselkumab Auto-Injector [Tremfya] SBDF · 2118740
Tremfya Injectable Product SBDG · 1928596
Tremfya BN · 1928593

📦 FDA Products & Package NDCs

3 products · 10 package NDCs

10 package NDCs map to RxCUI 2693095 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
57894-0640-01	1 SYRINGE in 1 CARTON (57894-640-01) / 1 mL in 1 SYRINGE	TREMFYA	Janssen Biotech, Inc.	2017-07-13
57894-0640-04	1 SYRINGE in 1 CARTON (57894-640-04) / 1 mL in 1 SYRINGE	TREMFYA	Janssen Biotech, Inc.	2017-07-13
57894-0640-06	1 SYRINGE in 1 CARTON (57894-640-06) / 1 mL in 1 SYRINGE (5...	TREMFYA	Janssen Biotech, Inc.	2025-03-25
57894-0640-11	1 SYRINGE in 1 CARTON (57894-640-11) / 1 mL in 1 SYRINGE	TREMFYA	Janssen Biotech, Inc.	2019-01-28
57894-0640-99	1 SYRINGE in 1 CARTON (57894-640-99) / 1 mL in 1 SYRINGE	TREMFYA	Janssen Biotech, Inc.	2019-01-28
57894-0650-02	1 VIAL, SINGLE-DOSE in 1 CARTON (57894-650-02) / 20 mL in 1...	TREMFYA	Janssen Biotech, Inc.	2024-09-11
57894-0651-02	1 SYRINGE in 1 CARTON (57894-651-02) / 2 mL in 1 SYRINGE (5...	TREMFYA	Janssen Biotech, Inc.	2024-09-11
57894-0651-04	2 CARTON in 1 CARTON (57894-651-04) / 1 SYRINGE in 1 CARTON...	TREMFYA	Janssen Biotech, Inc.	2025-03-20
57894-0651-22	1 SYRINGE in 1 CARTON (57894-651-22) / 2 mL in 1 SYRINGE (5...	TREMFYA	Janssen Biotech, Inc.	2024-09-11
57894-0651-92	1 SYRINGE in 1 CARTON (57894-651-92) / 2 mL in 1 SYRINGE (5...	TREMFYA	Janssen Biotech, Inc.	2024-09-11

Observed labelers: Janssen Biotech, Inc. (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1628	Inj., guselkumab, 1 mg	7	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.